EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical, Pathological and Molecular Insights on KRAS, NRAS, BRAF, PIK3CA and TP53 Mutations in Metastatic Colorectal Cancer Patients from Northeastern Romania

Vlad-Adrian Afrăsânie, Mihai-Vasile Marinca iD, Bogdan Gafton, Teodora Alexa-Stratulat iD, Alexandra Rusu iD, Eliza-Maria Froicu, Daniel Sur iD, Cristian Virgil Lungulescu, Larisa Popovici, Andrei-Vlad Lefter, Irina Afrăsânie, Anca-Viorica Ivanov und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241612679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Vlad-Adrian Afrăsânie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Regional Institute of Oncology, 700483 Iasi, Romania. Hauptthemen laut MEDLINE: Colonic Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Social Fund - the Human Capital Operational Programme, European Social Fund—the Human Capital Operational Programme, Romanian National Society of Medical Oncology (SNOMR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in RAS, BRAF, PIK3CA, and TP53 are well-established genetic abnormalities in metastatic colorectal cancer (mCRC). However, limited information is available for patients from Eastern Europe, including Romania. In this retrospective analysis, we investigated 104 mCRC patients from the Northeastern region of Romania to determine the frequency, distribution, coexistence, and clinicopathological and molecular correlations of these mutations. TP53 was the most frequently mutated gene (73.1%), followed by KRAS (45.2%) and PIK3CA (6.7%). Patients with KRAS mutant tumors and wild-type TP53 genotype were found to have no personal history of gastrointestinal cancer (p = 0.02, p = 0.007). KRAS mutations in exon 3 were associated with the female gender (p = 0.02) and the absence of lymph node invasion (p = 0.02). PIK3CA mutations were linked to the absence of lymph node invasion (p = 0.006). TP53 mutations were associated with KRAS mutations in exon 2 (p = 0.006), ulcerated histopathologic type (p = 0.04), and G2 differentiation (p = 0.01). It provides novel insights into genetic variations specific to the population from Northeastern Romania, which has been underrepresented in previous studies within Eastern Europe. Furthermore, our findings enable the development of genetic profiles in a developing country with limited access to specialized genetic tests and facilitate comparisons with other populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsRectal NeoplasmsHumansFemaleRomaniaProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Retrospective StudiesMutationClass I Phosphatidylinositol 3-KinasesTumor Suppressor Protein p53Membrane ProteinsGTP Phosphohydrolases

Stichwörter der Autor:innen

BRAFPIK3CARASTP53metastatic colorectal cancer

Substanzen

Proto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Class I Phosphatidylinositol 3-KinasesTumor Suppressor Protein p53Membrane ProteinsTP53 protein, humanKRAS protein, humanBRAF protein, humanPIK3CA protein, humanNRAS protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Regional Institute of Oncology, 700483 Iasi, Romania.
  • Department of Oncology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Department of Medical Oncology, The Oncology Institute "Prof. Dr. Ion Chiricuta", 400015 Cluj-Napoca, Romania.
  • 11th Department of Medical Oncology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
  • Department of Oncology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Cardiology, Emergency Clinical Hospital "Sf. Spiridon", 700111 Iasi, Romania.

ORCID-Profile: Mihai-Vasile Marinca, Teodora Alexa-Stratulat, Alexandra Rusu, Daniel Sur

Förderung

  • European Social Fund - the Human Capital Operational Programme
  • European Social Fund—the Human Capital Operational Programme
  • Romanian National Society of Medical Oncology (SNOMR)

Zitieren

APA

Afrăsânie, V. A., Marinca, M. V., Gafton, B., Alexa-Stratulat, T., Rusu, A., Froicu, E. M., Sur, D., Lungulescu, C. V., Popovici, L., Lefter, A. V., Afrăsânie, I., Ivanov, A. V., Miron, L., & Rusu, C. (2023). Clinical, Pathological and Molecular Insights on KRAS, NRAS, BRAF, PIK3CA and TP53 Mutations in Metastatic Colorectal Cancer Patients from Northeastern Romania. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241612679

Vancouver

Afrăsânie VA, Marinca MV, Gafton B, Alexa-Stratulat T, Rusu A, Froicu EM, et al. Clinical, Pathological and Molecular Insights on KRAS, NRAS, BRAF, PIK3CA and TP53 Mutations in Metastatic Colorectal Cancer Patients from Northeastern Romania. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241612679

BibTeX
@article{Afrsnie2023,
  author = {Afrăsânie, Vlad-Adrian and Marinca, Mihai-Vasile and Gafton, Bogdan and Alexa-Stratulat, Teodora and Rusu, Alexandra and Froicu, Eliza-Maria and Sur, Daniel and Lungulescu, Cristian Virgil and Popovici, Larisa and Lefter, Andrei-Vlad and Afrăsânie, Irina and Ivanov, Anca-Viorica and Miron, Lucian and Rusu, Cristina},
  title = {Clinical, Pathological and Molecular Insights on KRAS, NRAS, BRAF, PIK3CA and TP53 Mutations in Metastatic Colorectal Cancer Patients from Northeastern Romania},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241612679}
}
Kostenlos starten →